Skip to main content

Table 4 Level 2 (full text review) draft data abstraction tool (variables and definitions)

From: Barriers, supports, and effective interventions for uptake of human papillomavirus- and other vaccines within global and Canadian Indigenous peoples: a systematic review protocol

Variable Definition
Study characteristics
 Refid Study unique reference identification number
 Author Author last name, initials
 Year Year of publication
 Title Full title of manuscript
 Language Original language of publication
 Location Geographic location (country) of study
 Time Data collection period (start to end of recruitment)
 Data Data collection method(s)
 Funding Reported funding source(s) for study
 Population Indigenous population, community or ethnicity, as defined by study authors and eligibility criteria as reported by authors
 Target Target population (health care providers, vaccine recipients, parents, policy makers etc.)
 Report(s) Source(s) of reported barriers and/or supports
 Number Number of participants in study
 age_mean, age_sd Age of included participants [mean (SD), median (IQR), or categorical age, as reported]
 age_med, age-iqr
 age_cat
 Youth Study participants (or cohort of study participants) were < 18 years (Yes = 1, No = 0, Not Reported NR =99)
 Gender % female
 Gender_target Female, male, female and male
 Context Describe context of implementation (may include a description of the social, economic, policy, healthcare, organizational or other contextual facets that may influence scale implementation)
 Setting Describe study setting, as defined by study authors (may include characteristics of the locations, personnel, resources for implementation and/or criteria for eligibility as an implementation site that are used in the study
 setting_other Describe ‘other setting’, as defined by study authors
 Aimobj Study aims and objectives
 Design Study design
0 = RCT (Randomized controlled trial)
1 = NRCT (non-randomized controlled trial)
2 = cohort
3 = case control
4 = controlled before-after
5 = interrupted time series
6 = qualitative
7 = cross-sectional survey
8 = scoping, systematic or other synthesis
9 = mixed methods
10 = other
 design_other Describe ‘other study design’
 Sampling Describe sampling strategy
 Inclusion Study inclusion criteria, as reported by study authors
 Exclusion Study exclusion criteria, as reported by study authors
 vaccine_delivery Agency, authority, or group(s) administering vaccine
 vaccine_setting The environment (clinic, school or other) where the vaccine was delivered
 vaccine_type, vaccine_batch Type and/or batch of vaccine administered
 vaccine_series Describe how the vaccine administered (one dose, 3 doses etc.)
 vaccine_status Reported vaccination status of study participants (Yes = 1, No = 0)
 vaccine_statusdescribe If yes, describe whether full series, or only partial vaccination etc.
 mod_frame Authors describe explicitly, a health model, framework or theory utilized to frame their study (Yes = 1, No = 0, Not clear = 99)
 mod_frame_valid Did the researchers use or test the model/framework or theory? (Yes = 1, No = 0, Not reported = 99)
 mod_framedescribe Describe model, framework or theory
 Studylim Reported study limitations
 Onoffres Location of participants (on reserve, off reserve)
 onoffres_other Describe location of participants if participants are located off reserve
 Geography Relative geographic location as reported by study authors
 Ses Reported socioeconomic status of participants
 education_level Reported level of education of participants
 knowledge_gen* Reported participant knowledge about vaccination
 attitudes_gen* Reported participant attitudes about vaccination
 beliefs_gen* Reported participant beliefs about vaccination
 behaviors_gen* Reported participant behaviors regarding vaccination
 knowledge_HPV* Reported participant knowledge about HPV vaccination
 attitudes_HPV* Reported participant attitudes about HPV vaccination
 beliefs_HPV* Reported participant beliefs about HPV vaccination
 behaviors_HPV* Reported participant behaviors regarding HPV vaccination
 HPV_aware Awareness of HPV vaccine
 sex_status Participants reporting sexually active
 pap_status Participants reporting prior abnormal pap smear test
 STI_status Participants reporting previous STI
 HPV_status Participants reporting prior HPV infection
Barriers and Supports
 barrier* Describe barriers to vaccine (all types) subcategories will be determined inductively
 barrier_descr Describe which vaccine type the reported barriers discuss
 barrier_HPV* Describe barriers to HPV vaccine subcategories will be determined inductively
 support* Describe supports to vaccine (all types) subcategories will be determined inductively
 support_descr Describe which vaccine type the reported supports discuss
 support_HPV* Describe supports to HPV vaccine subcategories will be determined inductively
 recommend_gen* Describe study recommendations for vaccination (all types) subcategories will be determined inductively
 recommend_descr Describe which vaccine type the recommendations pertain to
 recommend_HPV* Describe study recommendations for HPV vaccination subcategories will be determined inductively
Vaccine Intervention Outcomes
 Outcomeimplem Describe primary and other outcomes of the implementation strategy, and how they were measured
 Outcomeintervent Describe primary and other outcomes of the intervention, and how they were measured
 Process Describe the process evaluation objectives and outcomes related to the mechanism by which the strategy is expected to work
 Intervention* Describe vaccine intervention subcategories will be determined inductively
 intervention_HPV* Describe HPV vaccine intervention subcategories will be determined inductively
 implemintervent Describe the implementation strategy
 HPVimplemintervent Describe the HPV-specific implementation strategy
 Subgroups Describe any subgroups or nested studies undertaken in the study
 RR Risk ratios reported
 RR_pvalue Reported p-values for RR
 OR Odds ratios reported
 OR_pvalue Reported p-values for OR
 Econintervent Methods for resource use, costs, economic outcomes and analysis for the intervention
 Econimplem Methods for resource use, costs, economic outcomes and analysis for the implementation strategy
 Samplesize Describe the sample sizes, calculations
 Analysis Describe analytic methods with rationale for methodological choice
 Subanalysis Describe subanalyses, representativeness and outcomes of subgroups including those recruited to specific research tasks
 Fidelimplem Fidelity of the implementation strategy as planned and adaptation to suit context and preferences
 Fidelintervent Fidelity of delivering the core components of the intervention
 Contextchange Describe contextual changes that may affect outcomes
 Harms Describe all important harms or unintended effects for each group
 vaccine_acceptance Reported factors influencing vaccine acceptance (study participant attitudes and beliefs)
 vaccine_uptake A rate or quantification of the number or proportion of the study population who received vaccine intervention
 vaccine_refuse A rate or quantification of the number or proportion of the population who refused vaccine intervention
 vaccine_hesitancy Describe reported factors relating to under-immunization, delay or questioning of vaccines, selecting only certain vaccines, desire to access a trustworthy healthcare provider [Specific description of hesitancy as a barrier (all types of vaccine)]
 hesitancy_HPV Describe reported factors relating to under-immunization, delay or questioning of vaccines, selecting only certain vaccines, desire to access a trustworthy healthcare provider [Specific description of hesitancy as a barrier (HPV vaccination)]
 CDGA_IC CGDA Intervention Category [142] – Informational, Behavioral, Environmental
 CGDA_IL CDGA Intervention Intensity Level [142] – active engagement to individual, active engagement to population, passive engagement with significant effort, passive engagement with minimal effort
 Interventimplic Describe policy, practice or research implications for the intervention, including sustainability
 Imlemimplic Describe policy, practice or research implications for the implementation strategy, specifically related to scalability
 Regulatory Ethics approval, trial/study registration (and protocol if available), governance of data use, presence of conflicts of interest etc.
  1. *denotes subcategories will be generated inductively